Published on 2 Nov 2022 on Zacks via Yahoo Finance
Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates
Glaukos (GKOS) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.19 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 15.09%. A quarter ago, it was expected that this glaucoma treatments developer would post a loss of $0.44 per share when it actually produced a loss of $0.83, delivering a surprise of -88.64%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.